DUBLIN–(BUSINESS WIRE)–The “Constipation Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market forDUBLIN–(BUSINESS WIRE)–The “Constipation Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for

Constipation Treatment Market to Grow by $8 Billion During 2025-2030 Driven by Increasing Demand for OTC Laxatives and Natural Remedies – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Constipation Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.

The global market for Constipation Treatment was valued at US$19.5 Billion in 2024 and is projected to reach US$27.5 Billion by 2030, growing at a CAGR of 5.9% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The growth in the constipation treatment market is driven by several factors, including the increasing prevalence of gastrointestinal disorders, the growing aging population, and the rise in demand for OTC medications. The expanding awareness of digestive health and the rising trend toward self-medication are also boosting the demand for natural and OTC treatment options.

Pharmaceutical advancements, such as the development of novel drugs with fewer side effects and more targeted action, are further contributing to market growth. Additionally, the increasing focus on preventive healthcare and lifestyle management is driving the adoption of dietary supplements and probiotics.

Report Scope

The report analyzes the Constipation Treatment market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

  • Segments: Disease Type (Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome with Constipation (IBS-C), Opioid-Induced Constipation (OIC)); Therapeutic Option (Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, GC-C Agonists, 5-HT4 Receptor Agonists).
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Laxatives segment, which is expected to reach US$12.3 Billion by 2030 with a CAGR of a 6.4%. The Chloride Channel Activators segment is also set to grow at 4.5% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $5.1 Billion in 2024, and China, forecasted to grow at an impressive 8.9% CAGR to reach $6.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott, AbbVie’s Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Constipation Treatment market report include:

  • Abbott
  • AbbVie
  • Albireo Pharma
  • AstraZeneca
  • Bausch Health Companies
  • Bayer
  • Cosmo Pharma
  • Daewoong
  • Ironwood Pharmaceuticals
  • Janssen Pharmaceutical
  • Mallinckrodt
  • Prestige Brands
  • Renexxion
  • Sanofi
  • Shionogi
  • Takeda Pharmaceutical Co.

Key Attributes:

Report AttributeDetails
No. of Pages194
Forecast Period2024-2030
Estimated Market Value (USD) in 2024$19.5 Billion
Forecasted Market Value (USD) by 2030$27.5 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal

MARKET OVERVIEW

  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Constipation Treatment – Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)

MARKET TRENDS & DRIVERS

  • Growing Prevalence of Gastrointestinal Disorders
  • Increasing Demand for Over-the-counter Laxatives and Natural Remedies
  • Technological Advancements in Prescription Medications
  • Rising Use of Probiotics and Fiber Supplements in Constipation Management
  • Expanding Geriatric Population Driving Demand for Treatment Solutions
  • Growing Awareness of Digestive Health and Preventive Care
  • Increased Adoption of Combination Therapies for Chronic Conditions
  • Rise in Demand for Home-based Constipation Treatment Products
  • Rising Focus on Gut Health and Holistic Treatment Approaches
  • Growing Popularity of Personalized Medicine in Constipation Treatment

For more information about this report visit https://www.researchandmarkets.com/r/spb1df

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Market Opportunity
Talus Logo
Talus Price(US)
$0.01237
$0.01237$0.01237
-4.55%
USD
Talus (US) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Crypto News: Donald Trump-Aligned Fed Governor To Speed Up Fed Rate Cuts?

Crypto News: Donald Trump-Aligned Fed Governor To Speed Up Fed Rate Cuts?

The post Crypto News: Donald Trump-Aligned Fed Governor To Speed Up Fed Rate Cuts? appeared on BitcoinEthereumNews.com. In recent crypto news, Stephen Miran swore in as the latest Federal Reserve governor on September 16, 2025, slipping into the board’s last open spot right before the Federal Open Market Committee kicks off its two-day rate discussion. Traders are betting heavily on a 25-basis-point trim, which would bring the federal funds rate down to 4.00%-4.25%, based on CME FedWatch Tool figures from September 15, 2025. Miran, who’s been Trump’s top economic advisor and a supporter of his trade ideas, joins a seven-member board where just three governors come from Democratic picks, according to the Fed’s records updated that same day. Crypto News: Miran’s Background and Quick Path to Confirmation The Senate greenlit Miran on September 15, 2025, with a tight 48-47 vote, following his nomination on September 2, 2025, as per a recent crypto news update. His stint runs only until January 31, 2026, stepping in for Adriana D. Kugler, who stepped down in August 2025 for reasons not made public. Miran earned his economics Ph.D. from Harvard and worked at the Treasury back in Trump’s first go-around. Afterward, he moved to Hudson Bay Capital Management as an economist, then looped back to the White House in December 2024 to head the Council of Economic Advisers. There, he helped craft Trump’s “reciprocal tariffs” approach, aimed at fixing trade gaps with China and the EU. He wouldn’t quit his White House gig, which irked Senator Elizabeth Warren at the September 7, 2025, confirmation hearings. That limited time frame means Miran gets to cast a vote straight away at the FOMC session starting September 16, 2025. The full board now features Chair Jerome H. Powell (Trump pick, term ends 2026), Vice Chair Philip N. Jefferson (Biden, to 2036), and folks like Lisa D. Cook (Biden, to 2028) and Michael S. Barr…
Share
BitcoinEthereumNews2025/09/18 03:14
Solana Price Prediction: Litecoin Latest Updates As Pepeto Gains Buzz With Analysts Calling 100x Potential

Solana Price Prediction: Litecoin Latest Updates As Pepeto Gains Buzz With Analysts Calling 100x Potential

The post Solana Price Prediction: Litecoin Latest Updates As Pepeto Gains Buzz With Analysts Calling 100x Potential appeared first on Coinpedia Fintech News The discussion around Solana price prediction and Litecoin price prediction is shifting toward a different headline: Pepeto (PEPETO). While majors like Solana and Litecoin still draw eyes, momentum is tilting to Pepeto, an Ethereum memecoin with working utility. The project has already raised more than $6.6 million in presale with entry at $0.000000153. Analysts and …
Share
CoinPedia2025/09/18 12:42
United Security Bancshares Declares Quarterly Cash Dividend

United Security Bancshares Declares Quarterly Cash Dividend

FRESNO, Calif.–(BUSINESS WIRE)–On December 16, 2025, the Board of Directors of United Security Bancshares (the “Company”) (NASDAQ: UBFO), the parent company of
Share
AI Journal2025/12/18 06:02